Development of [ 177 Lu]Lu-LNC1010 for peptide receptor radionuclide therapy of nasopharyngeal carcinoma.

MLA

Chen, Jianhao, et al. “Development of [ 177 Lu]Lu-LNC1010 for Peptide Receptor Radionuclide Therapy of Nasopharyngeal Carcinoma.” European Journal of Nuclear Medicine and Molecular Imaging, vol. 52, no. 1, Dec. 2024, pp. 247–59. EBSCOhost, https://doi.org/10.1007/s00259-024-06874-9.

APA

Chen, J., Pang, Y., Liao, X., Zhou, Y., Luo, Q., Wu, H., Zuo, C., Zhang, J., Lin, Q., Chen, X., Zhao, L., & Chen, H. (2024). Development of [ 177 Lu]Lu-LNC1010 for peptide receptor radionuclide therapy of nasopharyngeal carcinoma. European Journal of Nuclear Medicine and Molecular Imaging, 52(1), 247–259. https://doi.org/10.1007/s00259-024-06874-9

Chicago

Chen, Jianhao, Yizhen Pang, Xiyi Liao, Yangfan Zhou, Qicong Luo, Hua Wu, Changjing Zuo, et al. 2024. “Development of [ 177 Lu]Lu-LNC1010 for Peptide Receptor Radionuclide Therapy of Nasopharyngeal Carcinoma.” European Journal of Nuclear Medicine and Molecular Imaging 52 (1): 247–59. doi:10.1007/s00259-024-06874-9.